AI-generated summary
The authors surveyed members of the MASCC/ISOO Mucositis Study Group about their use of photobiomodulation for oral mucositis, receiving analyzable data from 78 respondents. Among users, technical settings varied widely, most used wavelengths near 650 nm intra-orally, and all PBM users reported pain relief, though high likelihood of relief was reported by only about one fifth of users. The authors note the practice is in early phases of adoption, with financial, time and training barriers.
- Who or what was studied
- Specialized practitioners (mostly dental practitioners or oral medicine specialists) who are members of the MASCC/ISOO Mucositis Study Group
- Wavelengths
- 650 nm
- Limits stated in the abstract
- The abstract describes a survey of practitioners' reported experience, which reflects their opinions and reports rather than controlled outcome data, and technical parameters varied widely.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 650 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Oral mucositis. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.